These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24041920)

  • 1. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization.
    Meng J; Shi C; Li L; Du Y; Xu Y
    Eur J Pharmacol; 2013 Oct; 718(1-3):87-97. PubMed ID: 24041920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
    Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced repolarization capacity: new potential antiarrhythmic strategy based on HERG channel activation.
    Szabó G; Farkas V; Grunnet M; Mohácsi A; Nánási PP
    Curr Med Chem; 2011; 18(24):3607-21. PubMed ID: 21774764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hERG channel activator, RPR260243, enhances protective
    Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
    Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of gefitinib-induced QT prolongation.
    Jie LJ; Li YD; Zhang HQ; Mao L; Xie HB; Zhou FG; Zhou TL; Xie D; Lin JL; Li GY; Cai BN; Zhang YH; Wang Y
    Eur J Pharmacol; 2021 Nov; 910():174441. PubMed ID: 34474028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
    Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
    Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.
    Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP
    Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
    Yue Y; Castrichini M; Srivastava U; Fabris F; Shah K; Li Z; Qu Y; El-Sherif N; Zhou Z; January C; Hussain MM; Jiang XC; Sobie EA; Wahren-Herlenius M; Chahine M; Capecchi PL; Laghi-Pasini F; Lazzerini PE; Boutjdir M
    Circulation; 2015 Jul; 132(4):230-40. PubMed ID: 25995318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba extract and ginkgolide antiarrhythmic potential by targeting hERG and ICa-L channel.
    Zhao X; Yao H; Yin HL; Zhu QL; Sun JL; Ma W; Shi YQ; Liang ZG; Li BX
    J Pharmacol Sci; 2013; 123(4):318-27. PubMed ID: 24225402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an hERG activator, ICA-105574, on electrophysiological properties of canine hearts.
    Asayama M; Kurokawa J; Shirakawa K; Okuyama H; Kagawa T; Okada J; Sugiura S; Hisada T; Furukawa T
    J Pharmacol Sci; 2013; 121(1):1-8. PubMed ID: 23238536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
    Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
    Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
    Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization.
    Zeng J; Laurita KR; Rosenbaum DS; Rudy Y
    Circ Res; 1995 Jul; 77(1):140-52. PubMed ID: 7788872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
    Qu Y; Gao B; Fang M; Vargas HM
    J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
    Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
    J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
    Perry MD; Ng CA; Mangala MM; Ng TYM; Hines AD; Liang W; Xu MJO; Hill AP; Vandenberg JI
    Cardiovasc Res; 2020 Jul; 116(8):1434-1445. PubMed ID: 31628797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
    Casis O; Olesen SP; Sanguinetti MC
    Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.